首页 › 伯基特淋巴瘤 › 威斯康星州 › Milwaukee
Milwaukee WI 伯基特淋巴瘤临床试验
16项针对 伯基特淋巴瘤的研究正在 Milwaukee及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
招募中3 期
- Medical College of Wisconsin, Milwaukee
Blinatumomab Consolidation in Real World
招募中观察性研究欢迎健康志愿者
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
招募中观察性研究
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
招募中2 期
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 距离 11 英里
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 距离 11 英里
- 以及另外 1 项
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
招募中2 期
- Children's Hospital of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
招募中1 期
- Medical College of Wisconsin, Milwaukee
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
招募中2 期
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
招募中3 期
- Children's Hospital of Wisconsin, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
招募中1/2 期
- Research Site, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
招募中1 期
- Froedtert & the Medical College of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
招募中
- Children's Wisconsin, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
招募中1 期
- Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
招募中观察性研究
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
招募中2 期
- Children's Hospital of Wisconsin, Milwaukee
其他城市的 伯基特淋巴瘤试验
- Houston, TX21 项研究
- Philadelphia, PA16 项研究
- Chicago, IL15 项研究
- Cincinnati, OH13 项研究
- New York City, NY13 项研究
- Atlanta, GA12 项研究
- Aurora, CO11 项研究
- Seattle, WA11 项研究
- Durham, NC10 项研究
- Boston, MA10 项研究
- Kansas City, MO10 项研究
- Los Angeles, CA10 项研究
Milwaukee的其他研究
- 乳腺癌23 项研究
- 癌症（所有类型）22 项研究
- 非小细胞肺癌22 项研究
- 多发性骨髓瘤21 项研究
- 肺癌21 项研究
- 前列腺癌20 项研究
- 滤泡性淋巴瘤19 项研究
- 非霍奇金淋巴瘤18 项研究
- 胰腺癌18 项研究
- 急性髓系白血病17 项研究
- 卵巢癌17 项研究
- 弥漫性大B细胞淋巴瘤16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。